Aptose Biosciences Inc (APTO)

Apr 27, 2025

(APS) Equity Trading Insights (APS:CA) - news.stocktradersdaily.com

Apr 27, 2025

Apr 23, 2025

Aptose Announces Auditor Not Standing for Re-Appointment - The Manila Times

Apr 23, 2025

Apr 23, 2025

Aptose Biosciences Inc. - MENAFN.com

Apr 23, 2025

Apr 23, 2025

Stocks In Play: Aptose Biosciences Inc. - Barchart.com

Apr 23, 2025

Apr 23, 2025

Aptose Biosciences to Present at 2025 Bloom Burton & Co. Healthcare Investor Conference - Nasdaq

Apr 23, 2025

Apr 23, 2025

Aptose to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference - The Manila Times

Apr 23, 2025

Apr 21, 2025

Aptose Biosciences announces change in accounting firm By Investing.com - Investing.com India

Apr 21, 2025

Apr 21, 2025

Aptose Biosciences announces change in accounting firm - Investing.com

Apr 21, 2025

Apr 19, 2025

(APS) Daily Stock Insights (APS:CA) - news.stocktradersdaily.com

Apr 19, 2025

Apr 13, 2025

Objective long/short (APS) Report (APS:CA) - news.stocktradersdaily.com

Apr 13, 2025

Apr 12, 2025

Aptose Biosciences (NASDAQ:APTO) Earns Sell Rating from Analysts at StockNews.com - Defense World

Apr 12, 2025

Apr 08, 2025

(APS) Technical Data (APS:CA) - news.stocktradersdaily.com

Apr 08, 2025

Apr 04, 2025

Aptose Biosciences (NASDAQ:APTO) Now Covered by StockNews.com - Defense World

Apr 04, 2025

Apr 03, 2025

Aptose Biosciences secures $25 million equity facility - MSN

Apr 03, 2025

Apr 02, 2025

Aptose Biosciences shares to delist from Nasdaq as of April 2 - Yahoo Finance

Apr 02, 2025

Apr 01, 2025

APTO stock touches 52-week low at $1.86 amid sharp annual decline - Investing.com Australia

Apr 01, 2025

Apr 01, 2025

APTO stock touches 52-week low at $1.86 amid sharp annual decline By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

Stock Market Shakes As Major Firms See Sharp Declines - Finimize

Apr 01, 2025

Apr 01, 2025

Nasdaq Surges 1%; US Construction Spending Rises In February - Benzinga

Apr 01, 2025

Apr 01, 2025

Why Aptose Biosciences (APTO) Stock Is Down Over 40% - Benzinga

Apr 01, 2025

Apr 01, 2025

Dow Dips Over 400 Points; ISM Manufacturing PMI Falls In March - Benzinga

Apr 01, 2025

Apr 01, 2025

Aptose Biosciences Says Shares to Be Delisted From Nasdaq - MarketScreener

Apr 01, 2025

Apr 01, 2025

Aptose Biosciences to be delisted from Nasdaq By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

Aptose Biosciences to be delisted from Nasdaq - Investing.com

Apr 01, 2025

Apr 01, 2025

Aptose Biosciences to Delist from Nasdaq in April - TipRanks

Apr 01, 2025

Apr 01, 2025

Aptose shares tumble following Nasdaq delisting decision By Investing.com - Investing.com Canada

Apr 01, 2025

Apr 01, 2025

Aptose Common Shares to Delist from Nasdaq as of April 2, 2025 - The Manila Times

Apr 01, 2025

Apr 01, 2025

Aptose Faces Nasdaq Exit: What This Means for Investors and Trading Options - Stock Titan

Apr 01, 2025

Mar 31, 2025

H.C. Wainwright raises Aptose stock target to $6, maintains Buy By Investing.com - Investing.com Canada

Mar 31, 2025

Mar 31, 2025

H.C. Wainwright raises Aptose stock target to $6, maintains Buy - Investing.com

Mar 31, 2025

Mar 30, 2025

Short Interest in Aptose Biosciences Inc. (NASDAQ:APTO) Drops By 56.6% - Defense World

Mar 30, 2025

Mar 30, 2025

HC Wainwright Forecasts Strong Price Appreciation for Aptose Biosciences (NASDAQ:APTO) Stock - Defense World

Mar 30, 2025

Mar 29, 2025

Aptose Biosciences price target raised to $6 from $2 at H.C. Wainwright - Yahoo Finance

Mar 29, 2025

Mar 28, 2025

Aptose Biosciences Inc. SEC 10-K Report - TradingView

Mar 28, 2025

Mar 28, 2025

Aptose Biosciences Advances AML Therapy and Strengthens Financial Position - TipRanks

Mar 28, 2025

Mar 28, 2025

Aptose Biosciences Brief: Adds Results to Date Highlight TUS Potential as an "Ideal" Third Drug to Include in AML Triplet Therapy - MarketScreener

Mar 28, 2025

Mar 28, 2025

Aptose Achieves Breakthrough in AML Treatment While Cutting Losses by 50% in 2024 - Stock Titan

Mar 28, 2025

Mar 28, 2025

Better Artificial Intelligence (AI) Stock: Nvidia vs. AMD - The Globe and Mail

Mar 28, 2025

Mar 28, 2025

Aptose Reports Year End 2024 Results and Corporate Highlights - The Manila Times

Mar 28, 2025

Mar 27, 2025

Aptose Biosciences (NASDAQ:APTO) Coverage Initiated at StockNews.com - Defense World

Mar 27, 2025

Mar 26, 2025

(APS) Strategic Market Analysis (APS:CA) - news.stocktradersdaily.com

Mar 26, 2025

Mar 25, 2025

3 Evergreen Financial Stocks to Buy With $3,000 and Hold Forever - The Globe and Mail

Mar 25, 2025

Mar 25, 2025

Bleichroeder LP Significantly Reduces Holdings in Aptose Biosciences Inc - GuruFocus

Mar 25, 2025

Mar 24, 2025

Aptose Biosciences Converts Debt to Equity with Hanmi Pharmaceutical By Investing.com - Investing.com South Africa

Mar 24, 2025

Mar 24, 2025

Aptose Biosciences Converts Debt to Equity with Hanmi Pharmaceutical - Investing.com

Mar 24, 2025

Mar 24, 2025

3 Reasons to Avoid DOX and 1 Stock to Buy Instead - The Globe and Mail

Mar 24, 2025

Mar 22, 2025

Bleichroeder LP Acquires Significant Stake in Aptose Biosciences Inc - GuruFocus.com

Mar 22, 2025

Mar 22, 2025

Trend Tracker for (APS) (APS:CA) - news.stocktradersdaily.com

Mar 22, 2025